$151.28 meals Payment -- Eli Lilly and Company to Dr. Matthew Walker

Eli Lilly and Company provided $151.28 in meals to a Psychiatry physician for Rinvoq.

This page provides a detailed analysis of a $151.28 meals payment from Eli Lilly and Company to Dr. Matthew Walker. Data is from the CMS Open Payments (Sunshine Act) database.

Payment Details

FieldValue
Amount$151.28
Payment Typemeals
Payment NatureFood and Beverage
Pharmaceutical CompanyEli Lilly and Company
PhysicianDr. Matthew Walker
NPI Number1456878332
Physician SpecialtyPsychiatry
LocationAnn Arbor, MI
Date of Payment2025-03-04
Related Drug/DeviceRinvoq
Conflict AssessmentLow -- Routine

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Eli Lilly and Company made a $151.28 meals payment to Matthew Walker, a Psychiatry specialist in Ann Arbor, MI. The payment was associated with Rinvoq. The payment of $151.28 to Dr. Matthew Walker from Eli Lilly and Company was for meals. This payment was associated with the drug Rinvoq, a medication for psychiatric conditions. The payment occurred on March 4, 2025, in Ann Arbor, MI.

Patient Guidance: What This Payment Means for You

This payment was for meals provided to your physician and is not directly related to your personal medical care. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

Payments for meals to physicians in Psychiatry are common, and this amount is relatively low compared to other payment types.

Regulatory Context: Sunshine Act Requirements

This payment falls under the Sunshine Act's reporting requirements for transfers of value from pharmaceutical companies to physicians.

Related Topics

This payment is related to the following healthcare transparency topics:

Understanding meals Payments

Food and beverage payments cover meals provided to physicians during pharmaceutical sales representative visits, medical conferences, and educational events. While individual meal payments tend to be small (often under $100), research published in JAMA Internal Medicine has shown that even modest meals can be associated with changes in prescribing behavior. Meal payments are the most common type of pharmaceutical payment to physicians.

Frequently Asked Questions About This Payment

What was this $151.28 payment for?

This was a meals payment of $151.28 from Eli Lilly and Company to Matthew Walker, categorized as "Food and Beverage". It was associated with Rinvoq. The payment was reported under the Sunshine Act (CMS Open Payments).

Does Matthew Walker accept pharmaceutical money?

Yes, Matthew Walker received this $151.28 payment from Eli Lilly and Company. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Matthew Walker's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this meals payment?

A meals payment of $151.28 is generally routine and common in the industry. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Psychiatry?

To compare this payment against Psychiatry averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Psychiatry physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Matthew Walker's relationship with Eli Lilly and Company?

The payment was specifically for 'Food and Beverage'. This $151.28 meals payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Psychiatry?

The physician's specialty is Psychiatry.

What should patients do after learning about this payment?

This payment was for meals provided to your physician and is not directly related to your personal medical care.

What else should I know about this meals payment?

The payment ID is OP-MNHYSALR-3X8HDW.

Related Reports

Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.